Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Promise of Personalized TCR-Based Cellular Immunotherapy for Cancer Patients
Marion Arnaud, Sara Bobisse, Johanna Chiffelle, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 11

Showing 11 citing articles:

Neoantigens: promising targets for cancer therapy
Na Xie, Guobo Shen, Wei Gao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 476
Heterogeneity and molecular landscape of melanoma: implications for targeted therapy
Yasaman Zohrab Beigi, Hossein Lanjanian, Reyhane Fayazi, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 11
T-Cell Receptor Repertoire Sequencing in the Era of Cancer Immunotherapy
Meredith Frank, Kaylene Lu, Can Erdogan, et al.
Clinical Cancer Research (2022) Vol. 29, Iss. 6, pp. 994-1008
Open Access | Times Cited: 30
Adoptive T Cell Therapy Targeting MAGE-A4
Kapil Chandora, Akshay Chandora, Anwaar Saeed, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 413-413
Open Access
Exploring the dynamic landscape of immunopeptidomics: Unravelling posttranslational modifications and navigating bioinformatics terrain
Daniel Flender, Frédérique Vilenne, Charlotte Adams, et al.
Mass Spectrometry Reviews (2024)
Open Access | Times Cited: 2
CrossDome: an interactive R package to predict cross-reactivity risk using immunopeptidomics databases
André Faustino Fonseca, Dinler A. Antunes
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Transgenic HA-1-Specific CD8+ T-Lymphocytes Selectively Target Leukemic Cells
Artem Pilunov, Dmitrii Romaniuk, Anton Shmelev, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1592-1592
Open Access | Times Cited: 5
Anticalin®-based therapeutics: Expanding new frontiers in drug development
Aizea Morales‐Kastresana, Martin Siegemund, Stefan Haak, et al.
International review of cell and molecular biology (2022), pp. 89-106
Closed Access | Times Cited: 6
The Value of Microbes in Cancer Neoantigen Immunotherapy
Junrui Tian, Jian Ma
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2138-2138
Open Access | Times Cited: 3
Assessing TCR identity, knock-in efficiency, and potency for individualized TCR-T cell therapy
Julien Camperi, Srinidhi Devarajan, Andy McKay, et al.
Journal of Immunological Methods (2023) Vol. 517, pp. 113491-113491
Closed Access | Times Cited: 2
From mouse to human: Metabolic targeting of cancer with TEG-based immunotherapy
Inez Johanna Gan
(2022)
Open Access
Page 1

Scroll to top